CTNM — Contineum Therapeutics, Inc. | XLV Holdings | StockAdder

(CTNM)

Contineum Therapeutics, Inc.

Live chart and latest CTNM stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

CTNM News

Is Contineum Therapeutics, Inc. (CTNM) Stock Outpacing Its Medical Peers This Year?

Feb 4, 2026 Stock Titan

Pre-planned stock sale by Contineum (CTNM) chief scientific officer

Apr 6, 2026 Investing.com

Contineum Therapeutics CSO sells $56k in CTNM stock

Apr 6, 2026 Business Wire

Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Mar 13, 2026 Yahoo Finance

Contineum Therapeutics, Inc. (NASDAQ:CTNM) surges 10%; retail investors who own 51% shares profited along with institutions

Jan 27, 2026 The Globe and Mail

Contineum Therapeutics Expands ATM Facility, Highlights Pipeline Progress

Mar 6, 2026 Stock Titan

Daniel Lorrain sells via 10b5-1; CTNM (NASDAQ: CTNM) Form 144 notice

Apr 6, 2026 The Globe and Mail

RBC Capital Remains a Buy on Contineum Therapeutics, Inc. Class A (CTNM)

Mar 7, 2026 Investing.com

Contineum Therapeutics (CTNM) CMO sells $54,220 in stock

Mar 2, 2026 Business Wire

Contineum Therapeutics Reports Fourth-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones

Mar 5, 2026 Stock Titan

Contineum Therapeutics (Nasdaq: CTNM) starts proposed $75.0M underwritten stock sale

Dec 11, 2025 Yahoo Finance

Here's Why We're Not Too Worried About Contineum Therapeutics' (NASDAQ:CTNM) Cash Burn Situation

Sep 30, 2025 Stock Titan

Contineum Therapeutics (CTNM) CSO sells shares under 10b5-1 plan

Mar 2, 2026 Stock Titan

Hear Contineum management at 2026 Leerink healthcare conference webcast

Mar 3, 2026 Business Wire

Contineum Therapeutics Announces Pricing of Upsized $90.0 Million Public Offering